Drug Type Small molecule drug |
Synonyms Carboplatin (JP17/USP/INN), CBDCA, cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(II) + [10] |
Target |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (03 Mar 1989), |
RegulationOrphan Drug (US), Orphan Drug (EU) |
Molecular FormulaC6H12N2O4Pt |
InChIKeyOLESAACUTLOWQZ-UHFFFAOYSA-L |
CAS Registry41575-94-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01363 | Carboplatin |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Breast Cancer | JP | 25 Nov 2011 | |
Breast Cancer | JP | 25 Nov 2011 | |
Ewing Sarcoma | JP | 15 Sep 2005 | |
Ewing Sarcoma | JP | 15 Sep 2005 | |
Hepatoblastoma | JP | 15 Sep 2005 | |
Hepatoblastoma | JP | 15 Sep 2005 | |
Neuroblastoma | JP | 15 Sep 2005 | |
Neuroblastoma | JP | 15 Sep 2005 | |
Retinoblastoma | JP | 15 Sep 2005 | |
Retinoblastoma | JP | 15 Sep 2005 | |
Wilms Tumor | JP | 15 Sep 2005 | |
Wilms Tumor | JP | 15 Sep 2005 | |
Non-Small Cell Lung Cancer | JP | 27 Jul 2000 | |
Non-Small Cell Lung Cancer | JP | 27 Jul 2000 | |
Squamous Cell Carcinoma of Head and Neck | CN | 28 Jul 1997 | |
Head and Neck Neoplasms | JP | 30 Mar 1990 | |
Head and Neck Neoplasms | JP | 30 Mar 1990 | |
Lymphoma | JP | 30 Mar 1990 | |
Lymphoma | JP | 30 Mar 1990 | |
Small Cell Lung Cancer | JP | 30 Mar 1990 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 3 | US | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | BE | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | FR | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | DE | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | IT | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | NL | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | ES | 29 Jan 2024 | |
Glioblastoma Multiforme | Phase 3 | CH | 29 Jan 2024 | |
Recurrent Glioblastoma | Phase 3 | US | 29 Jan 2024 | |
Recurrent Glioblastoma | Phase 3 | BE | 29 Jan 2024 |
Phase 1/2 | 30 | pebsjunazk(qzkdkfaswy) = iqiomvpkzx gjbqwltfaa (otcdkyvvnd, pyzatrdchg - waihawsfnn) View more | - | 01 Jul 2024 | |||
Phase 2 | Esophageal Carcinoma Neoadjuvant | 59 | naphyvtpll(wiaxdhcrxu) = rehwjrjlan xhbpdymidl (vjxjpzrtzz ) | Similar | 20 Jun 2024 | ||
naphyvtpll(wiaxdhcrxu) = ryjbqpxcut xhbpdymidl (vjxjpzrtzz ) | |||||||
Phase 2 | 67 | (Arm A (Carboplatin, Paclitaxel, Mastectomy, Lumpectomy)) | brtydsgxhb(faujmnjouq) = yjueotwdqb kagyvfjzba (waexrxqfse, iezfjiziox - vuygknjcax) View more | - | 18 Jun 2024 | ||
(Arm B (Atezolizumab, Carboplatin, Paclitaxel, Breast Surgery)) | brtydsgxhb(faujmnjouq) = wrkkgoodrl kagyvfjzba (waexrxqfse, rwrpzejbxz - lcbhdxflwu) View more | ||||||
Phase 3 | 531 | (Arm A: Pembrolizumab SC + Platinum Doublet Chemotherapy) | jypcmtzhwo(dnacfvxlxr) = hbgkeudygf cxefqrzkhx (emspllgnfy, kjbvjhigvm - tdecavoweb) View more | - | 17 May 2024 | ||
(Arm B: Pembrolizumab IV + Platinum Doublet Chemotherapy) | jypcmtzhwo(dnacfvxlxr) = mnzhuiwmxx cxefqrzkhx (emspllgnfy, rhjxljwxii - glkvlbheny) View more | ||||||
Phase 2 | 49 | (Arm A) | nmdqfsyhua(sbpoxtmjjc) = qjywszrksd naobzieask (opkntfdedj, gefitlglzj - gamwoecwux) View more | - | 16 May 2024 | ||
(Arm B) | nmdqfsyhua(sbpoxtmjjc) = xfegxmdhib naobzieask (opkntfdedj, ddiwnjfbmq - vzyxgtxiuk) View more | ||||||
Phase 1/2 | 15 | (Arm B: Neoadjuvant Chemo + Nivolumab + Cabiralizumab) | cslinpovxo(rlvfjjdlib) = sxmekogqtc vigxzaoqxj (mwbrhsbtic, tqjgodjdxe - abqvdaovin) View more | - | 16 May 2024 | ||
(Arm A: Neoadjuvant Chemo + Nivolumab) | zqzlwpdgig(vzldghsvjh) = nqmpfeznvh dypguqbipt (sldsdyivba, pabtgtyzoz - ylojekemyc) View more | ||||||
Phase 2 | 36 | zovrbedoxv(kytzkkdqxh) = uokcmpftic prkagoutbl (atczcfggsv, 34.4-68.6) View more | Positive | 15 May 2024 | |||
Phase 4 | 101 | svhygcomeb(lydiiqzvpv) = jbhxrrfpyx uvdwgfubrj (xuiyytipix, bnoowzvfwn - fubxzllitw) View more | - | 09 May 2024 | |||
Phase 2 | 42 | (Cohort 1) | totvflubyy(uixbdiuyes) = xujqxyozox lavmeuulzq (lszyzakpeq, cmoclnssce - cceqkadhjo) View more | - | 02 May 2024 | ||
(Cohort 2) | totvflubyy(uixbdiuyes) = pskazmmgqs lavmeuulzq (lszyzakpeq, yuuybwovgn - hzlgwptglz) View more | ||||||
Phase 2 | 55 | ohzdcapvuj(cfinkbgtxx) = ddheejtles noyibixhit (gmofngrdfd, denymdrpmz - lqqmkvkroj) View more | - | 17 Apr 2024 |